Concepedia

Markus Artelsmair

MA

Statistics

Publications

5

Citations

197

H-Index

5

Active since

2017

Affiliations

AstraZeneca (Sweden)(Current)

AstraZeneca (United States)

King's College London

Ohio University

University of Cambridge

Markus Artelsmair is an author at AstraZeneca (Sweden) specializing in biochemistry, catalysis, and chemistry.

ORCID

Top concepts

Publications per year

2017–2022

5

Publications

5

Cucurbit[7]uril as a Supramolecular Artificial Enzyme for Diels–Alder Reactions

Aniello Palma, Markus Artelsmair, Guanglu Wu et al. · Angewandte Chemie International Edition · 2017 · 94 citations · Full text

, , +13

In-Cell Quantification of Drugs by Magic-Angle Spinning Dynamic Nuclear Polarization NMR

Andrea Bertarello, Pierrick Berruyer, Markus Artelsmair et al. · Journal of the American Chemical Society · 2022 · 39 citations · Full text

Cucurbit[7]uril as a Supramolecular Artificial Enzyme for Diels–Alder Reactions

Aniello Palma, Markus Artelsmair, Guanglu Wu et al. · Angewandte Chemie · 2017 · 37 citations

, , +14

Late-occurring and Long-circulating Metabolites of GABAA2,3 Receptor Modulator AZD7325 Involving Metabolic Cyclization and Aromatization: Relevance to MIST Analysis and Application for Patient Compliance

Chungang Gu, Markus Artelsmair, Charles S. Elmore et al. · Drug Metabolism and Disposition · 2018 · 17 citations · Full text

Synthesis of C‐14 labeled GABA<sub>A</sub> α2/α3 selective partial agonists and the investigation of late‐occurring and long‐circulating metabolites of GABA<sub>A</sub> receptor modulator AZD7325

Markus Artelsmair, Chungang Gu, Richard J. Lewis et al. · Journal of Labelled Compounds and Radiopharmaceuticals · 2018 · 10 citations · Full text

Rows per page

1–5 of 5